Plain-English translation of NCT06950593 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called transcutaneous electrical spinal cord stimulation (TESS) for people who have had a stroke and have weakness or paralysis in their arm and hand. The treatment uses mild electrical pulses delivered through electrodes placed on the skin over the spine, combined with physical exercises designed to retrain your arm. Researchers hope this treatment will help improve arm strength and movement better than exercise alone.
Most stroke survivors with moderate to severe arm weakness don't have effective treatment options available—standard therapy only works well for about 25% of patients. This trial exists to see if electrical spinal stimulation combined with targeted training might offer a new way to help people regain arm function.
You likely qualify if…
You likely don't qualify if…
You would attend 15 sessions of treatment at the research facility. During each session, electrodes would be placed on your skin over your spine, and you would receive either real electrical stimulation or a placebo version (you won't know which). You would then spend about 30 minutes doing targeted exercises designed to improve your arm strength and movement. The study includes three assessment visits: before treatment starts, after all 15 sessions are complete, and at a follow-up appointment.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States